welcome
TechCrunch

TechCrunch

Technology

Technology

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive | TechCrunch

TechCrunch
Summary
Nutrition label

89% Informative

Isomorphic Labs is the AI drug discovery platform that was spun out of Google's DeepMind in 2021 .

The $600 million round was led by Thrive Capital , with participation from GV , and existing investor Google ’s parent Alphabet .

The funding will accelerate further development of Isomorphic 's AI drug design engine and support its goal of bringing its discovered drugs to clinical trials.

VR Score

92

Informative language

93

Neutral language

72

Article tone

formal

Language

English

Language complexity

63

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

Affiliate links

no affiliate links